 | Vol. 9.33 – 8 September, 2023 |
| |
|
|
| Utilizing radiation injury to model intestinal pathology, scientists reported that the Interleukin-33 (IL-33)/ST2 axis, an immunomodulatory pathway monitored clinically as an intestinal injury biomarker, regulated intrinsic epithelial regeneration by inducing production of epidermal growth factor (EGF). [Nature Communications] |
|
|
|
 | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators screened the expression profile of circRNAs in intestinal tissue exosomes collected from intestinal ischemia/reperfusion mice and identified circEZH2_005 as a significantly downregulated exosomal circRNA. [Nature Communications] |
|
|
|
| Scientists described an essential role for TET3-mediated DNA production of 5hmC to protect intestinal epithelial integrity from pathogenic infection and chemical stressors by promoting the expression of genes involved in Notch and Wnt signaling pathways. [Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
| Researchers conducted transcriptome sequencing on pairs of sessile serrated lesions and corresponding normal control samples. They knocked down and overexpressed ANXA10 in colorectal cancer cells to examine its effects on cell malignant ability. [Cell Death & Disease] |
|
|
|
| Investigators found that insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) was upregulated in CRC tissues. Clinically, the elevated IGF2BP3 level was predictive of a poor prognosis. Functionally, IGF2BP3 enhanced CRC tumorigenesis and progression both in vitro and in vivo. [Cell Death & Disease] |
|
|
|
| Scientists investigated the protective effects of Taraxacum coreanum Nakai extract on inflammatory responses and intestinal barrier dysfunction in lipopolysaccharide-stimulated Caco-2 cells. [Journal Of Ethnopharmacology] |
|
|
|
| Researchers explored the role and mechanism of Nrf2 inhibition in oxaliplatin-based chemosensitivity of colorectal cancer (CRC). In vitro, they applied 4-octyl itaconate to activate Nrf2, and used lentivirus to knock down Nrf2 in CRC cell lines. [Scientific Reports] |
|
|
|
| Investigators evaluated the risk of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)-induced diarrhea using spheroids of human and monkey crypt-derived intestinal stem cells. Intestinal spheroids exhibited higher toxic susceptibility to EGFR-TKIs than Caco-2 cells. [Toxicology In Vitro] |
|
|
|
| Researchers investigated the protective effects of tea polyphenols against heat-stress-induced damage in bovine intestinal epithelial cells and explored the underlying mechanisms. [Animal Biotechnology] |
|
|
|
|
| Despite the availability of a variety of therapeutic compounds and improved management strategies, one-third of ulcerative colitis patients do not benefit from the existing treatments. The authors summarize available evidence on oral drugs, which are now being explored in clinical trials. [Expert Opinion On Emerging Drugs] |
|
|
|
| | The license provides Palisade Bio with the exclusive worldwide rights to develop, manufacture, and commercialize Giiant’s proprietary targeted prodrug platform focused on therapies for the multi-billion dollar inflammatory bowel disease market. [Palisade Bio. Inc.] |
|
|
|
|
| October 1 – 4, 2023 Toronto, Ontario, Canada |
|
|
|
|
|
| University of Oxford – Oxford, England, United Kingdom |
|
|
|
| University of Australia – Adelaide, South Australia, Australia |
|
|
|
| Cedars-Sinai – Los Angeles, California, United States |
|
|
|
| University of South California – Los Angeles, California, United States |
|
|
|
| Coventry University – Coventry, England, United Kingdom |
|
|
|
|